In the first major enforcement action involving the importation of illegal tobacco products by the new administration, and on the heels of the appointment of the new acting director of the U.S. Food and Drug Administration (FDA) Center for Tobacco Products, FDA and U.S. Customs and Border Protection (CBP) seized illegal e-cigarettes valued at nearly $34 million. This operation underscores the ongoing efforts by federal agencies to combat the influx of unauthorized tobacco products into the U.S.
The joint operation took place in Chicago and targeted shipments of e-cigarettes that violated the Federal Food, Drug, and Cosmetic Act (FD&C Act) and intellectual property rights for unauthorized use of protected trademarks. All the e-cigarettes seized lacked premarket authorization from the FDA and therefore cannot be legally marketed or distributed in the U.S. The seized e-cigarettes were primarily imported from China and were intended for distribution across the U.S.
For the first time, FDA also sent letters to 24 tobacco importers and entry filers responsible for importing these illegal e-cigarettes, advising them that it is a federal crime to make false statements or entries to the U.S. government. The FDA seeks information on the steps they have taken to ensure compliance with applicable federal tobacco laws and regulations.
This action illustrates that FDA and CBP continue to crack down on illegal tobacco products imported from abroad. The agency has been actively working to address the challenges posed by the rapidly evolving e-cigarette market, which has seen a surge in illegal products that appeal to younger demographics over the years. For example, the FDA and CBP previously seized $18 million of illegal e-cigarettes at the Los Angeles International Airport in 2023, seized $7 million of illegal e-cigarettes at a warehouse in Miami, and announced operations in June and October 2024 that resulted in the seizure of illegal e-cigarettes valued at more than $77 million.
The FDA and CBP’s collaborative efforts are part of a broader strategy to monitor and intercept illegal tobacco products at U.S. ports of entry. These seizures serve as a warning to importers, manufacturers, and distributors attempting to circumvent U.S. law.
Why It Matters
Federal agency action against illegal e-cigarettes reflects a solidification of the agencies’ enforcement focus on these products over the last few years. These enforcement actions may stem from increased public pressure on the FDA from both pro- and anti-nicotine groups. The growing pressure on the FDA for an effective solution to illegal e-cigarettes raises fundamental questions about the agency’s regulatory purpose. To the extent FDA cannot control illegal e-cigarette sales, it creates market conditions in which legitimate industry members are squeezed out by actors with no interest in compliance.
